A number of research firms have changed their ratings and price targets for E I Du Pont De Nemours And (NYSE: DD):

  • 8/30/2017 – E I Du Pont De Nemours And was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “DuPont’s adjusted earnings for second-quarter 2017 topped the Zacks Consensus Estimate. Revenues also rose year over year and beat expectations. DuPont has outperformed the industry it belongs to over a year. DuPont is well placed to gain from its cost-cutting and productivity improvement measures. The company's aggressive actions to cut operational costs should continue to lend support to its earnings. Its agriculture business is also gaining from new product launches. The company has numerous new products in its pipeline that should contribute to top line growth. DuPont is also moving forward with its planned mega-merger with Dow Chemical, which is expected to create significant synergies. However, DuPont is exposed to raw material cost pressure and currency headwind and also faces certain challenges in its nutrition & health and electronics businesses. Its agriculture business is also not out of the woods yet.”
  • 8/29/2017 – E I Du Pont De Nemours And had its “buy” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $96.00 price target on the stock.
  • 8/22/2017 – E I Du Pont De Nemours And was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $92.00 price target on the stock. According to Zacks, “DuPont’s adjusted earnings for second-quarter 2017 topped the Zacks Consensus Estimate. Revenues also rose year over year and beat expectations. DuPont has outperformed the industry it belongs to over the past three months. DuPont is well placed to gain from its cost-cutting and productivity improvement measures. The company's aggressive actions to cut operational costs should continue to lend support to its earnings. Its agriculture business is also gaining from new product launches. The company has numerous new products in its pipeline that should contribute to top line growth. DuPont is also moving forward with its planned mega-merger with Dow Chemical, which is expected to create significant synergies.”
  • 8/21/2017 – E I Du Pont De Nemours And was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “DuPont’s adjusted earnings for second-quarter 2017 topped the Zacks Consensus Estimate. Revenues also rose year over year and beat expectations. DuPont has outperformed the industry it belongs to over the past three months. DuPont is well placed to gain from its cost-cutting and productivity improvement measures. The company's aggressive actions to cut operational costs should continue to lend support to its earnings. Its agriculture business is also gaining from new product launches. The company has numerous new products in its pipeline that should contribute to top line growth. DuPont is also moving forward with its planned mega-merger with Dow Chemical, which is expected to create significant synergies. However, DuPont is exposed to raw material cost pressure and currency headwind and also faces certain challenges in its nutrition & health and electronics businesses. Its agriculture business is also not out of the woods yet.”
  • 8/19/2017 – E I Du Pont De Nemours And was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 8/4/2017 – E I Du Pont De Nemours And was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 7/27/2017 – E I Du Pont De Nemours And was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating.
  • 7/24/2017 – E I Du Pont De Nemours And was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “DuPont has outperformed the industry it belongs to over a year. DuPont is well placed to gain from its cost-cutting and productivity improvement measures. The company's aggressive actions to cut operational costs should continue to lend support to its earnings. DuPont is also moving forward with its planned mega-merger with Dow Chemical, which is expected to create significant synergies. The company also has numerous new products in its pipeline that should contribute to top line growth. However, DuPont is exposed to raw material cost pressure and currency headwind and also faces certain challenges in its nutrition & health and electronics businesses. Its agriculture business is also not out of the woods yet.”
  • 7/13/2017 – E I Du Pont De Nemours And was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating.

Shares of E I Du Pont De Nemours And Co (NYSE DD) remained flat at $83.93 during mid-day trading on Wednesday. 34,861,021 shares of the company were exchanged. The company has a market cap of $72.83 billion, a price-to-earnings ratio of 32.79 and a beta of 1.76. E I Du Pont De Nemours And Co has a 1-year low of $66.02 and a 1-year high of $86.36. The stock has a 50-day moving average price of $82.87 and a 200 day moving average price of $80.79.

E I Du Pont De Nemours And (NYSE:DD) last announced its quarterly earnings results on Tuesday, July 25th. The basic materials company reported $1.38 EPS for the quarter, topping the Zacks’ consensus estimate of $1.29 by $0.09. The business had revenue of $7.42 billion for the quarter, compared to analysts’ expectations of $7.28 billion. E I Du Pont De Nemours And had a return on equity of 29.17% and a net margin of 11.57%. The business’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.24 EPS. Equities analysts expect that E I Du Pont De Nemours And Co will post $3.89 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Monday, July 31st will be given a $0.38 dividend. The ex-dividend date of this dividend is Thursday, July 27th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.81%. E I Du Pont De Nemours And’s dividend payout ratio is currently 59.38%.

In other news, SVP Benito Cachinero sold 10,621 shares of E I Du Pont De Nemours And stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $81.67, for a total value of $867,417.07. The sale was disclosed in a document filed with the SEC, which is available through this link. 0.31% of the stock is currently owned by company insiders.

E. I. du Pont de Nemours and Company is a science and technology-based company. It operates through six segments: Agriculture, Electronics & Communications (E&C), Industrial Biosciences, Nutrition & Health, Performance Materials and Protection Solutions. Its Agriculture segment includes products, such as corn hybrids and soybean varieties, herbicides, fungicides and insecticides.

Receive News & Stock Ratings for E I Du Pont De Nemours And Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for E I Du Pont De Nemours And Co and related stocks with our FREE daily email newsletter.